TRCT
IMED

Tower Research Capital (TRC)’s PureFunds ETFx HealthTech ETF IMED Stock Holding History

Tower Research Capital (TRC)’s Portfolio IMED Stock Details IMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-196
Closed -$6K – 4426
2017
Q2 		$6K Buy
+196
New +$5.55K ﹤0.01% 1950

Tower Research Capital (TRC)'s IMED Position: Q3 2017 in Review

Tower Research Capital (TRC) sold out of PureFunds ETFx HealthTech ETF (IMED) in Q3 2017, closing a stake of 196 shares — an estimated $6K sold.

Tower Research Capital (TRC) first reported a position in IMED in Q2 2017 and held it in 1 quarter. The position peaked at $6K in Q2 2017. 0 funds tracked by Wall St. Rank hold IMED as of Q3 2017.

  • Tower Research Capital (TRC) reported no remaining PureFunds ETFx HealthTech ETF position as of Q3 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 196 PureFunds ETFx HealthTech ETF shares in Q3 2017, an estimated $6K.
  • Tower Research Capital (TRC) first reported a position in PureFunds ETFx HealthTech ETF in Q2 2017 and held it in 1 quarter.
  • Tower Research Capital (TRC)'s PureFunds ETFx HealthTech ETF position peaked at $6K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held PureFunds ETFx HealthTech ETF as of Q3 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2017, filed 14 Nov 2017.